EACR 2025

Michał Rudnik is a Scientist in the Oncology and Immunology  Group at InSphero, where he manages service and publicly funded projects. He is responsible for the development of immune-competent 3D tumor models to support the evaluation of immunotherapeutics, including bispecific antibodies, immune checkpoint inhibitors, and cancer vaccines. Michał earned his PhD in Immunology from the University Hospital Zurich, where he investigated immunoregulatory mechanisms of myeloid cell populations in autoimmune diseases.

Dr. Bärbel Ulmer, Director of Business Development for Europe at InSphero, Zürich, strives to blend scientific innovation in the field of 3D culture and stem cell research with commercial applications in drug discovery and toxicology. In her previous role as the Head of Tissue Engineering at DiNAQOR AG, she fast-tracked gene therapy solutions through human induced pluripotent stem cells (iPSC) and engineered heart tissue platforms. Her academic journey includes a PhD in Developmental Biology from the University of Hohenheim and Hebrew University, a postdoc at Cornell University and a lecturer position at the Institue of experimental Toxicology and Pharmakology at the Medical University Clinic Hamburg-Eppendorf.